You have reached the HIVandHepatitis.com legacy site. Please visit our new site at hivandhepatitis.com

HIVandHepatitis.com
HIV and AIDS Topics
Top News Articles
 
FDA-approved Treatments 
Experimental Treatments
Women / Children
Metabolic Complications
Opportunistic Infections
 Google Custom Search

World Health Organization Declares H1N1 Influenza Has Reached Pandemic Level

By Liz Highleyman

On June 11, 2009, the World Health Organization (WHO) declared that the ongoing outbreak of influenza A - H1N1 -- formerly dubbed swine flu -- has become a pandemic. The agency raise the pandemic alert level from 5 to 6 (its highest level) after an emergency meeting of infectious disease experts.

Importantly, a level 6 pandemic means sustained person-to-person transmission of an infectious disease within multiple regions of the world -- it does not indicate anything about the severity of disease. To date, the H1N1 flu still appears to be a relatively mild illness, with a mortality rate comparable to or lower than that of a typical seasonal flu. The last influenza pandemic -- due to the Hong Kong flu -- was declared in 1968.

In the U.S., most H1N1 flu deaths have occurred in people with underlying health problems. Pregnant women and people with compromised immunity -- which includes HIV positive people -- are at increased risk for severe disease. So far, this flu has infected a greater proportion of young people than usual, suggesting older individuals born before 1957 may have some residual immunity from a past flu outbreak.

H1N1 continues to spread in North America, Europe, and Asia, but the southern hemisphere, including Australia, is of particular concern since flu outbreaks are typically worse during the winter.

The primary effect of the WHO declaration is that it will trigger countries (whether or not they have reported any cases) to implement disease control plans, though many have already done so.

According to the latest WHO statistics, there have been 27,737 confirmed cases of H1N1 flu in 74 countries, with 141 deaths. In the U.S., as of June 5, the Centers for Disease Control and Prevention (CDC) has tallied 13,217 cases (affecting all 50 states, Washington, DC, and Puerto Rico), with 27 deaths.

For further information, including the latest statistics and tips for flu prevention, see the CDC's H1N1 influenza web site at www.cdc.gov and the WHO flu web site at www.who.int.

Previous HIVandHepatitis.com H1N1 influenza coverage:

CDC Issues Flu Treatment Guidelines and Public Health Service Updates Antiretroviral Therapy Recommendations for Pregnant Women with HIV
(May 29, 2009)

H1N1 Swine Flu Update and CDC Interim Guidance for Clinicians Treating People with HIV
(May 3, 2009)

U.S. Declares Public Health Emergency as Swine Flu Outbreak Spreads
(April 28, 2009)

6/12/09

Sources

Centers for Disease Control and Prevention. H1N1 Flu (Swine Flu). Updated June 10, 2009.

World Health Organization. Influenza A(H1N1). Updated June 11, 2009.

CNN. WHO declares swine flu pandemic. June 11, 2009.


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


Protease Inhibitors
Agenerase (amprenavir)
Aptivus
(tipranavir)
Crixivan
(indinavir)
Invirase
(saquinavir hard gel)
Kaletra
(lopinavir/ritonavir)
Lexiva
(fosamprenavir)
Norvir
(ritonavir)
Prezista
(darunavir)
Reyataz
(atazanavir)
Viracept
(nelfinavir)
Nucleoside / Nucleotide Reverse
Transcriptase Inhibitors
Combivir (zidovudine/lamivudine)
Epivir (lamivudine; 3TC)
Emtriva (emtricitabine; FTC)
Epzicom (abacavir + lamivudine)
Retrovir (zidovudine; AZT)
Trizivir (abacavir + zidovudine +lamivudine)
Truvada  (tenofovir / emtricitabine)
Videx (didanosine; ddI)
Viread (tenofovir)
Zerit (stavudine; d4T)
Ziagen (abacavir)
non Nucleoside Reverse
Transcriptase Inhibitors
Etravirine (Intelence; TMC125)
Rescriptor (delavirdine)
Sustiva (efavirenz)
Viramune (nevirapine)
Entry Inhibitors
(including Fusion Inhibitors)
Fuzeon (enfuvirtide, T-20)
Selzentry
(maraviroc)
Fixed Dose Combinations
Atripla (efavirenz + emtricitabine + tenofovir)
Combivir (zidovudine + lamivudine)
Trizivir (abacavir + zidovudine + lamivudine)
Truvada (tenofovir + emtricitabine)
Integrase Inhibitor
Isentress (raltegravir)